unknown by unknown
Reply to the Editor:
Matsubara and associates are among several recent
investigators who have suggested that extended three-field
lymphadenectomy provides a survival benefit in patients
undergoing esophagectomy for carcinoma (Matsubara T,
Ueda M, Yanagidi O, Nakajima T, Nishi M. How Exten-
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sive Should Lymph Node Dissection Be for Cancer of the
Thoracic Esophagus? J Thorac Cardiovasc Surg 1994;107:
1073-8). Among 171 of their patients undergoing esophagec-
tomy for carcinoma of the thoracic esophagus, 29 had
involvement of only one lymph node (60% had metastasis to
a cervical lymph node and 32% to an upper perigastric
node). Reported 3- and 5-year survivals in these patients
with “early” disease were 75% and 60%, respectively. As
indicated by Altorki and Skinner, other Japanese surgeons
have reported 5-year survival of approximately 30% in
patients with stage III esophageal cancer treated with sub-
total esophagectomy and three-field lymph node dissection.
All of these reports, like that of Altorki and Skinner,
involve relatively small numbers of patients. And in-
continuity dissection of cervical and upper mediastinal
lymph nodes may confound the accurate pathologic dis-
tinction between supraclavicular nodes and infraclavicular
paraesophageal or upper mediastinal nodes. It cannot be
argued, however, that some patients with esophageal
carcinoma will have a solitary cervical lymph node metas-
tasis, just as some patients with bronchogenic carcinoma
may have a solitary brain metastasis. At times, albeit in a
relatively small number, long-term survival in both groups
is achieved with an aggressive surgical approach to both
the primary tumor and the metastasis. In my personal
experience, however, the finding of an unsuspected left
cervical or recurrent laryngeal nerve lymph node metas-
tasis at the time of transhiatal esophagectomy and a
cervical esophagogastric anastomosis for carcinoma of the
thoracic esophagus has uniformly signaled advanced dis-
ease. Among 11 such patients we have treated, despite the
addition of postoperative radiation therapy to the neck
and mediastinum, there have been no survivors beyond 1
year. It is difficult to rationalize a recommendation for
routine three-field lymphadenectomy for esophageal can-
cer in the hope that the patient with lymph node metas-
tasis will prove to be among the minority with involvement
of only a single cervical lymph node and therefore be
potentially benefited by the lymph node resection. The
added time and potential morbidity of this approach
simply do not seem justified on the basis of the existing
limited data. With a growing number of patients with
esophageal carcinoma being relegated to chemoradiation
therapy without surgical input even being sought, it will be
increasingly difficult to convince the medical community
that more radical surgery is the answer to this disease. The
meticulous lymph node dissections of Matsubara, Altorki
and Skinner, and others is clearly identifying a heretofore
unappreciated incidence of cervical lymph node metasta-
ses in patients with carcinoma of the intrathoracic esoph-
agus. It remains to be proven, however, that the demon-
stration of these nodal metastases through routine three-
field lymphadenectomy is truly conferring a survival
benefit in these patients.
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